2025 Interim Results

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK version of the EU Market Abuse Regulation (2014/596) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. Upon the publication of this announcement via a Regulatory Information Service, this inside information will be considered to be in the public domain.

3 June 2025

Chesterfield Special Cylinders Holdings plc

(“CSC " or the “Company”)

2025 Interim Results

Chesterfield Special Cylinders Holdings plc (AIM: CSC), formerly Pressure Technologies plc (AIM: PRES), is pleased to announce its unaudited interim results for the 26 weeks to 29 March 2025 ("the period").

1 Adjusted EBITDA is earnings before interest, tax, depreciation, amortisation and other exceptional costs

2 Adjusted operating loss is operating loss before disposal of discontinued operation, amortisation and other exceptional costs

3 Net cash / (borrowings) comprises cash and cash equivalents and borrowings, but excludes asset finance lease liabilities and right of use asset lease liabilities

4 Adjusted basic loss per share is reported earnings per share before disposal of discontinued operation, amortisation and other exceptional costs

Financial highlights

Operational and strategic highlights

Current trading and outlook

Chris Walters, Chief Executive of Chesterfield Special Cylinders Holdings plc, commented:

"We are pleased with the progress being made towards our 2028 targets, with recent strategically significant overseas defence contract awards and our first order for large-scale UK hydrogen storage systems.

Record full-year revenue performance is anticipated for hydrogen and Integrity Management services, while strong order intake and order book coverage underpin second-half revenue expectations and a return to full-year Adjusted EBITDA profitability, in line with market expectations."

Additional Information

The person responsible for arranging release of this announcement on behalf of the Company is Chris Walters, Chief Executive.

For further information, please contact:

COMPANY DESCRIPTION

www.csc-holdings.com

Located in Sheffield, Chesterfield Special Cylinders Holdings plc was founded on its leading market position as a designer and manufacturer of high-pressure systems serving the global energy, defence and industrial gases market.

The Company has one trading subsidiary.

· Chesterfield Special Cylinders - www.chesterfieldcylinders.com 

Business review

In the first half of FY25, Chesterfield Special Cylinders ("CSC") made good strategic progress towards its 2028 targets first announced in February 2025, securing strategically significant contracts from key hydrogen and overseas defence customers and ramping up Integrity Management services.

Overall revenue of £5.4 million (2024: £6.5 million) and Adjusted EBITDA loss of £1.3 million (2024: loss of £0.7 million) reflect the phasing of defence and hydrogen newbuild contracts, weighted heavily towards the second half of the year, and the later-than-expected start to major UK naval Integrity Management deployments.

Strong order intake of £14.2 million (2024: £10.3 million) underpinned an order book of £18.0 million at the end of the period (2024: £14.9 million).

The sale of the Precision Machined Components division (PMC) completed in October 2024, with initial cash consideration of £4.8 million, strengthening the balance sheets and providing increased working capital flexibility. Proceeds from the sale facilitated the repayment of the £1.0 million term loan facility. No further proceeds are anticipated in respect of this disposal.

Defence

CSC continues to focus on the delivery of the existing order book for UK and overseas defence customers and remains well positioned for growth in global defence markets over the medium term.

Defence revenue of £4.4 million in the first half of the year (2024: £5.5 million) reflects the phasing of newbuild contract milestones and the later-than-expected start to Integrity Management UK naval deployments.

The defence outlook for the remainder of FY25 and FY26 is underpinned by overseas defence contracts secured recently for submarine and surface ship programmes for the Royal Australian, Royal Canadian, US and Spanish navies.

Over the longer term, the backdrop of geopolitical tensions and increasing global defence budgets underpin a strong outlook for submarine and surface ship newbuild programmes in the UK and overseas.

Hydrogen

CSC remains well positioned in the emerging market for pressurised hydrogen storage and transportation.

Hydrogen revenue of £0.7 million (2024: £0.6 million) reflects in-factory lifecycle support services for static storage and road trailers, while newbuild project activity is weighted to the second half of the year.

A strategically significant contract was secured in March 2025 to supply large-scale hydrogen storage systems to the bp Aberdeen Hydrogen Hub project, with system delivery planned for Q1 2026.

In April 2025, the UK government reaffirmed its commitment to support domestic green hydrogen production growth through the Hydrogen Allocation Rounds (HAR). Five HAR1 projects have already been approved by the government and a shortlist of 27 HAR2 projects has been announced. CSC is well positioned to supply static hydrogen storage systems and road trailers to HAR funded projects, which are expected to be operational between 2026 and 2029.

One major contract award under HAR1 that was previously expected in Q2 2025 is now expected in Q4 2025, following later-than-expected funding approval by UK government. The project is expected to be operational from Q1 2028.

The anticipated growth in green hydrogen production and offtake from HAR and privately funded projects is driving fleet expansion plans for hydrogen road trailers in the UK. CSC has signed a cooperation agreement with a leading European Type 4 composite cylinder manufacturer, enabling CSC to supply advanced lightweight modular hydrogen storage systems and road trailers to meet this growing UK demand.

Outside the UK hydrogen market, a contract was secured in Q1 2025 to supply high-pressure hydrogen storage systems to leading French refuelling station specialists, Atawey for delivery in Q4 FY25.

Hydrogen revenue expected in the second half of the year is supported by full order book coverage across newbuild static storage contracts and in-factory lifecycle support services, underpinning an anticipated record hydrogen revenue performance for the full year.

Integrity Management services

Revenue of £2.1 million (2024: £1.8 million) in the first half of the year reflects the level of activity on major UK naval deployments.

Momentum has continued into the second half, with revenue from UK naval and international offshore services deployments underpinning an anticipated record performance for the full year.

The longer-term outlook for Integrity Management services remains strong, covering the in-situ lifecycle support and recertification of safety-critical pressure systems, including future UK naval deployments. CSC is also well positioned for new European naval opportunities in FY26 and beyond.

Outlook

Significantly stronger performance is expected from CSC in the second half of the year. The strong order intake in the first half of the year and robust order book coverage support second-half revenue expectations and a return to full-year Adjusted EBITDA profitability, in line with market expectations.

Chris Walters

Chief Executive

3 June 2025

Financial review

Revenue and profitability

Revenue of £5.4 million (2024: £6.5 million) in the first half of FY25 generated gross profit of £1.0 million at 19% margin (2024: £1.5 million at 23% margin).

Overhead costs remained unchanged in the period at £2.7 million (2024: £2.7 million), generating an operating loss before profit on disposal of the discontinued operation and exceptional costs of £1.7 million (2024: loss of £1.1 million).

Allowing for depreciation charges of £0.4 million (2024: £0.4 million), the Adjusted EBITDA loss was £1.3 million (2024: loss of £0.7 million).

Profit on the disposal of the PMC division was £0.4 million, as shown in note 11.

Exceptional costs of £0.7 million were incurred in the period (2024: £0.2 million), with £0.6 million related to the payment of management retention and bonus awards, contingent on completion of the sale of PMC. These were paid in the first quarter of FY25.

Cashflow

The Company reported a net cash inflow of £1.9 million in the period (2024: outflow of £0.4 million). This was driven largely by the net proceeds from the sale of PMC of £4.4 million, partly offset by the subsequent repayment of the outstanding term loan of £1.0 million.

Additional factors were the adjusted EBITDA loss of £1.3 million, exceptional costs of £0.7 million and working capital inflows of £1.0 million. Finally, capital expenditure, lease repayments and interest payments totalled £0.4 million.

Net cash / (debt), which comprises cash, borrowings, finance lease liabilities and right of use asset lease liabilities, at the end of the period was a positive balance of £1.4 million in net cash (28 September 2024: net debt of £1.4 million). Net cash / (borrowings), which comprises cash and borrowings only, at the end of the period was £1.9 million (28 September 2024: net borrowings of £0.9 million).

Impairment reviews

The Company tests periodically for impairment, in accordance with IAS 36, if there are indicators that tangible fixed assets might be impaired.

The impairment methodology identifies one Cash Generating Units ("CGU's") within the Company, being CSC. The CGU is assessed for potential indicators of impairment, including internal or external factors or events that could reduce the recoverable value of the fixed assets of the Company. If indicators of impairment are identified, a full impairment review is undertaken to determine the recoverable amount of the CGU.

An impairment review was undertaken for CSC as at 29 March 2025. The review concluded that no impairment was required in these Interim Results.

Chris Walters

Chief Executive

3 June 2025

Condensed Consolidated Statement of Comprehensive Income

For the 26 weeks ended 29 March 2025

Condensed Consolidated Statement of Financial Position

As at 29 March 2025

Condensed Consolidated Statement of Changes in Equity

For the 26 weeks ended 29 March 2025

For the 26 weeks ended 30 March 2024

Condensed Consolidated Statement of Changes in Equity (continued)

For the 52 weeks ended 28 September 2024

The above balance at 28 September 2024 includes £9,313,000 of assets and £5,412,000 of liabilities classified as held for sale. It excludes a net £2,015,000 in inter-company balances owed by the PMC division to the continuing operations of the Company.

Condensed Consolidated Cash Flow Statement

For the 26 weeks ended 29 March 2025

Net debt at 30 March 2024 includes £267,000 of cash and £1,873,000 of lease liabilities relating to the PMC division, which was later classified as a disposal Group held for sale.

Net debt at 28 September 2024 excludes £354,000 of cash and £1,725,000 of lease liabilities in the PMC disposal Group held for sale.

Notes to the Condensed Consolidated Interim Financial Statements

1. General information

Chesterfield Special Cylinders Holdings plc (formerly Pressure Technologies plc) is incorporated in England and Wales and is quoted on AIM, a market operated by the London Stock Exchange.

These unaudited interim condensed consolidated financial statements for the 26 weeks ended 29 March 2025 were approved by the Board of Directors on 2 June 2025.

These financial statements may contain certain statements about the future outlook of Chesterfield Special Cylinders Holdings plc. Although the Directors believe their expectations are based on reasonable assumptions, any statements about future outlook may be influenced by factors that could cause actual outcomes and results to be materially different.

2. Basis of preparation

The Company's unaudited interim results for the 26 weeks ended 29 March 2025 ("Interim Results") are prepared in accordance with the Company's accounting policies which are based on the recognition and measurement principles of the UK-adopted International Accounting Standards in conformity with the requirements of the Companies Act 2006. As permitted, the Interim Results have been prepared in accordance with the AIM rules and not in accordance with IAS 34 "Interim financial reporting" and therefore the interim information is not in full compliance with International Accounting Standards.

The interim condensed consolidated financial statements are prepared under the historical cost convention as modified to include the revaluation of certain financial instruments. The accounting policies adopted in the preparation of the interim condensed consolidated financial statements are consistent with those followed in the preparation of the Company's annual consolidated financial statements for the year ended 28 September 2024. The principal accounting policies of the Company have remained unchanged from those set out in the Company's 2024 annual report and financial statements. The Principal Risks and Uncertainties of the Company are also set out in the Company's 2024 annual report and financial statements and are unchanged in the period.

The financial information for the 26 weeks ended 29 March 2025 and 30 March 2024 has not been audited and does not constitute full financial statements within the meaning of Section 434 of the Companies Act 2006.

The Company's 2024 financial statements for the 52 weeks ended 28 September 2024 were prepared under UK-adopted International Accounting Standards. The auditor's report on these financial statements was unqualified and did not contain statements under Sections 498(2) or (3) of the Companies Act 2006 and they have been filed with the Registrar of Companies.

3. Going concern

The Directors have considered and assessed whether the Company will be able to meet its obligations as they fall due for the period of at least 12 months from the date of these Interim Results. These interim condensed financial statements have been prepared on a going concern basis. The Company's business activities, together with the factors likely to affect its future development, performance and position, are set out in the Company's 2024 annual report and financial statements.

In making this assessment, the Directors have considered a range of factors, including the prospects for the markets the Company serves; the position and intentions of competitors; the customer base of the Company and any reliance on a small number of customers; the supply chain of the Company and any reliance on key suppliers; staff attrition and the risk of losing any key members of staff; any actual or threatened litigation; relationships with HMRC and regulators; historic, current and projected financial performance and cash flow; relationships with debt and equity funders and the likely availability of external funding; and the plans and intentions of management. The Directors have also considered the economic backdrop and geopolitical risks to economic activity from the Russia-Ukraine conflict, the instability in the Middle East, and the imposition of global trading tariffs by the US government.

In undertaking their assessment, the Directors have prepared financial projections for a period of at least 12 months from the date of approval of these Interim Results. The current economic conditions have introduced additional uncertainty into the Directors' assessment, such that future potential outcomes are more difficult to estimate. The Directors have therefore considered a number of sensitivities to their projections to quantify potential downside risks to future financial performance.

Management has produced projections for the period up to September 2026, taking account of reasonably plausible changes in trading performance and market conditions, which have been reviewed by the Directors. In particular, the projections reflect:

· as a result of the sale of the PMC division just after the FY24 year end, the projections include the net cash proceeds from the disposal of £4.4 million (£4.8 million initial cash consideration, less £0.4 million agreed locked-box adjustment)

· the Group is dependent on the profitability of CSC as its only trading operation

Notes to the Condensed Consolidated Interim Financial Statements (continued)

· CSC has historically been dependent on large UK defence contracts for its profitability. During the projection period, revenue from UK defence contracts will be lower while revenue from the hydrogen energy market and contracts with overseas defence customers are expected to increase. This change in mix is expected to result in lower revenues and earnings for CSC, which has been factored into the financial projections.

· There are internal and external risks to CSC's performance over the projection period, which have been modelled and considered in the sensitised cases.

The base case forecast demonstrates that the Company is projected to generate operating profits and cash in the current financial year and beyond.

Due to the significance of revenues from UK hydrogen projects in the base case and the history of delays in this market, the Directors have developed the downside scenario to account for reasonably plausible delays to the placement of major hydrogen orders. The Directors believe that any material delays to hydrogen contracts will give sufficient time to take mitigating actions and adjust operating costs and capital expenditure plans to maintain cash generation, as illustrated by the financial projections for the downside case. 

In addition, management has considered the sensitivity of the base and downside cases to the following risks:

· Later defence contract milestones than forecast, resulting from customer delays; and

· In-house operational delays, delays to the supply of material and components by suppliers, and delays in the performance of work by subcontractors.

The Company believes that these other factors are individually less likely to be material to the achievement of the projections than potential delays in defence contract milestones and hydrogen orders, but in the event that they occur together with these risks, they may have a negative impact on cash flow at certain points in the projection period.

In the event of the delays identified above the Company's cash resources could become limited. However, the Company would look to mitigate the impact, partially or fully, by pulling forward contracted work from other customers, and through normal working capital management and other cash preservation initiatives.

The Directors also note that the Company has net assets of £9.0 million at 29 March 2025.

Reflecting management's confidence in delivering large defence contracts and winning new hydrogen contracts, and having repaid its debt facilities in full, the Directors have concluded that the Company does have sufficient financial resources to meet its obligations as they fall due for the next 12 months and no material uncertainty relating to going concern has been identified.

The Company continues to adopt the going concern basis in preparing these interim results. Consequently, these interim results do not include any adjustments that would be required if the going concern basis of preparation were to be inappropriate.

4. Sale of Precision Machined Components ("PMC") division

On 8 October 2024, the Company completed the sale of the PMC division in order to strengthen the Company's balance sheet and cash position and support strategic investment into Chesterfield Special Cylinders.

In the Company's audited financial statements for the 52 weeks ended 28 September 2024, the PMC division was classified as an asset held for sale and discontinued operation in accordance with "IFRS5 - Non-current Assets Held For Sale and Discontinued Operations".

The result of the discontinued operation is shown in note 11.

Notes to the Condensed Consolidated Interim Financial Statements (continued)

5. Segmental analysis of Revenue, Adjusted EBITDA and Operating Loss

Revenue by sector

Revenue recognition

The Company's pattern of revenue recognition is as follows:

Notes to the Condensed Consolidated Interim Financial Statements (continued)

5. Segmental analysis of Revenue, Adjusted EBITDA and Operating Loss (continued)

For the 26-week period ended 29 March 2025 (unaudited)

1 CSC operations comprise the results of the Chesterfield Special Cylinders Limited trading subsidiary.

2 Central costs comprise costs related to the public listing of Chesterfield Special Cylinders Holdings plc (formerly Pressure Technologies plc).

3 Segmental net assets comprise the net assets of each segment adjusted to reflect the elimination of the cost of investment in subsidiaries and the provision of financing loans provided by Chesterfield Special Cylinders Holdings plc.

The result of the discontinued operation is shown in note 11.

Notes to the Condensed Consolidated Interim Financial Statements (continued)

5. Segmental analysis of Revenue, Adjusted EBITDA and Operating Loss (continued)

For the 26-week period ended 30 March 2024 (unaudited) - continuing operations only

1 CSC operations comprise the results of the Chesterfield Special Cylinders Limited trading subsidiary.

2 Central costs comprise costs related to the public listing of Chesterfield Special Cylinders Holdings plc (formerly Pressure Technologies plc).

3 Segmental net assets comprise the net assets of each segment adjusted to reflect the elimination of the cost of investment in subsidiaries and the provision of financing loans provided by Chesterfield Special Cylinders Holdings plc.

The result of the discontinued operation is shown in note 11.

Notes to the Condensed Consolidated Interim Financial Statements (continued)

5. Segmental analysis of Revenue, Adjusted EBITDA and Operating Loss (continued)

For the 52 week period ended 28 September 2024 (audited) - continuing operations only

1 CSC operations comprise the results of the Chesterfield Special Cylinders Limited trading subsidiary.

2 Central costs comprise costs related to the public listing of Chesterfield Special Cylinders Holdings plc (formerly Pressure Technologies plc).

3 Segmental net assets comprise the net assets of each segment adjusted to reflect the elimination of the cost of investment in subsidiaries and the provision of financing loans provided by Chesterfield Special Cylinders Holdings plc.

The result of the discontinued operation is shown in note 11.

Notes to the Condensed Consolidated Interim Financial Statements (continued)

6. Exceptional costs

Items that are incurred outside the normal course of business and/or that are non-recurring are considered as exceptional costs and are disclosed separately on the face of the Condensed Consolidated Statement of Comprehensive Income.

An analysis of the amounts presented as exceptional costs is as follows:

Exceptional costs relating to discontinued operations are shown in note 11.

7. Taxation

The taxation credit in the period relates to a slight decrease in the net deferred tax liability of the Company. This is driven by a decrease in deferred tax liabilities in relation to accelerated tax depreciation.

Taxation charges and credits relating to the discontinued operation are shown in note 11.

8. Loss per ordinary share

The calculation of basic loss per share is based on the loss attributable to ordinary shareholders divided by the weighted average number of shares in issue during the period.

The calculation of diluted loss per share is based on basic loss per share, adjusted to allow for the issue of shares on the assumed conversion of all dilutive share options.

Adjusted loss per share shows loss per share after adjusting for the impact of amortisation charges, impairment charges and any other exceptional items, and for the estimated tax impact, if any, of those costs. Adjusted loss per share is based on the loss as adjusted divided by the weighted average number of shares in issue.

Notes to the Condensed Consolidated Interim Financial Statements (continued)

8. Loss per ordinary share (continued)

The effect of anti-dilutive potential shares is not disclosed in accordance with IAS 33.

The Company adjusted loss per share is calculated as follows:

Notes to the Condensed Consolidated Interim Financial Statements (continued)

8. Loss per ordinary share (continued)

The effect of anti-dilutive potential shares is not disclosed in accordance with IAS 33.

The Company adjusted loss per share is calculated as follows:

Notes to the Condensed Consolidated Interim Financial Statements (continued)

8. Loss per ordinary share (continued)